NCT07040306View on ClinicalTrials.gov

A Clinical Follow-up Study on Drug Therapy for Graves' Disease Patients in China

RecruitingOBSERVATIONAL

Enrollment

1,000

Participants

Timeline

Start Date

November 14, 2012

Primary Completion Date

December 1, 2030

Study Completion Date

December 1, 2030

Conditions

Graves´ Disease

Interventions

DRUG

Methimazole(MMI)

Determine the enrolled GD patients and adjust the dosage of methimazole according to the 2016 American Thyroid Association guidelines. Conduct thyroid function, liver function, TRAb, and blood routine tests during outpatient follow-up to observe the treatment effect and provide medication guidance.

Trial Locations (1)

110001

RECRUITING

The First Affiliated Hospital of China Medical University, Shenyang

All Listed Sponsors

lead

First Hospital of China Medical University

OTHER

NCT07040306 - A Clinical Follow-up Study on Drug Therapy for Graves' Disease Patients in China | Biotech Hunter | Biotech Hunter